ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Etropal Ad

Etropal Ad (0OOX)

4.98
0.00
(0.00%)
마감 23 1월 1:30AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
4.98
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
4.98 52주 범위 4.98
market_cap
전일 종가
4.98
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
0.00
발행 주식
5,000,000
배당수익률
-
주가수익률
-889.29
주당순이익(EPS)
-0.01
매출
11.2M
순이익
-28k

Etropal Ad 정보

섹터
Med, Dental, Hosp Eq-whsl
산업
Med, Dental, Hosp Eq-whsl
웹사이트
본부
Etropole, Bgr
설립됨
-
Etropal Ad is listed in the Med, Dental, Hosp Eq-whsl sector of the 런던증권거래소 with ticker 0OOX. The last closing price for Etropal Ad was BGN4.98. Over the last year, Etropal Ad shares have traded in a share price range of BGN 4.98 to BGN 4.98.

Etropal Ad currently has 5,000,000 shares in issue. The market capitalisation of Etropal Ad is BGN24.90 million. Etropal Ad has a price to earnings ratio (PE ratio) of -889.29.

0OOX 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1004.984.984.9800DE
4004.984.984.9800DE
12004.984.984.9800DE
26004.984.984.9800DE
52004.984.984.9800DE
156004.984.984.9800DE
260004.984.984.9800DE

0OOX - Frequently Asked Questions (FAQ)

What is the current Etropal Ad share price?
The current share price of Etropal Ad is BGN 4.98
How many Etropal Ad shares are in issue?
Etropal Ad has 5,000,000 shares in issue
What is the market cap of Etropal Ad?
The market capitalisation of Etropal Ad is BGN 24.9M
What is the 1 year trading range for Etropal Ad share price?
Etropal Ad has traded in the range of BGN 4.98 to BGN 4.98 during the past year
What is the PE ratio of Etropal Ad?
The price to earnings ratio of Etropal Ad is -889.29
What is the cash to sales ratio of Etropal Ad?
The cash to sales ratio of Etropal Ad is 2.22
What is the reporting currency for Etropal Ad?
Etropal Ad reports financial results in BGN
What is the latest annual turnover for Etropal Ad?
The latest annual turnover of Etropal Ad is BGN 11.2M
What is the latest annual profit for Etropal Ad?
The latest annual profit of Etropal Ad is BGN -28k
What is the registered address of Etropal Ad?
The registered address for Etropal Ad is BUL. RUSKI 191, ETROPOLE, 2180
What is the Etropal Ad website address?
The website address for Etropal Ad is www.etropal.eu
Which industry sector does Etropal Ad operate in?
Etropal Ad operates in the MED, DENTAL, HOSP EQ-WHSL sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M
ThoroughBread ThoroughBread 2 분 전
SFIO .0028 sleeper.
SFIO
glens0 glens0 3 분 전
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 5 분 전
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 5 분 전
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 6 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 6 분 전
KPIFF
wadegarret wadegarret 7 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 7 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 7 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 9 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 9 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 9 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 10 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 12 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 12 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 12 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 14 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 14 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 15 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 17 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 18 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 18 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 19 분 전
Whats 305
RNVA

최근 히스토리

Delayed Upgrade Clock